CLINICAL_TRIALS
trial_result
· 2009-03-11
Clinical Trial Update: PPI Sequencing Study [Phase 4]
Summary
A Phase 4 clinical trial evaluating proton pump inhibitor sequencing for gastroesophageal reflux disease sponsored by AstraZeneca has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Gastro-Oesophageal Reflux Disease | Phase 4 | Status: COMPLETED